Showing results (701-710 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|July 10, 2003
Cancer vaccine THERATOPE- BiomiraDrugs in R&D|July 10, 2003
CBP 1011: Colirest, HematrolDrugs in R&D|November 19, 2020
Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CISIgor V Maev, Yury A Kucheryavyy, Natalya B Gubergrits, et al.Drugs in R&D|December 1, 2020
Dosing Considerations for Antibodies Against COVID-19Million A Tegenge, Iftekhar Mahmood, Evi Struble, et al.Drugs in R&D|December 13, 2016
Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch StudyFrank R Ernst, Walter Sandulli, Riad Elmor, et al.Drugs in R&D|January 12, 2017
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification SystemNasir Idkaidek, Tawfiq Arafat, Hazim Hamadi, et al.Drugs in R&D|January 12, 2017
Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case ReportAtsushi Tanaka, Tsukasa Nakamura, Eiichi Sato, et al.Drugs in R&D|January 13, 2017
Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in NeonatesChristine M Sanfilippo, Catherine M Allaire, Heleen H DeCoryDrugs in R&D|January 13, 2017
Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation ModelSteven M Brunelli, Scott P Sibbel, David Van Wyck, et al.Pageof 89